For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dronedarone hydrochloride - Atrial fibrillation
PAD Profile : Dronedarone hydrochloride - Atrial fibrillation Important
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed the use of the dronedarone national shared care protocol for primary care prescribers treating existing adult patients in primary care with Atrial Fibrillation.
Dronedarone will continue to have a RED traffic light status for this indication.
The use of the shared care protocol will support prescribers with the appropriate monitoring of these patients.
The Area Prescribing Committee recommends that dronedarone must only be initiated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation (AF) in exceptional circumstances when there is a clinical need for dronedarone to be prescribed:
- Where other treatments cannot be used or have failed
OR
- In line with NICE Guidance CG180 https://www.nice.org.uk/guidance/CG180
In these circumstances dronedarone must be initiated by a specialist and will be considered as RED on the traffic light system for the above indications.
Patients currently being prescribed dronedarone in primary care should be reviewed and referred back to specialist care if appropriate.